This is a discussion-oriented meeting and the formats of both the symposium and workshop are designed to allow ample time for stimulating discussions focused on understanding the current state of the art, knowledge gaps, and unanswered questions in the field. The ultimate goal is to achieve some convergence on defining the research priorities and opportunities that would enable us to translate our understanding of alpha-synuclein functions in health and disease to accelerate ongoing and future efforts aimed at developing effective therapies for the treatment of Parkinson’s disease and related synucleinopathies.  

Read more on https://synuclein.epfl.ch/.